Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
60,500,377
-
Shares change
-
+5,651,432
-
Total reported value, excl. options
-
$1,095,067,241
-
Value change
-
+$103,341,807
-
Put/Call ratio
-
18%
-
Number of buys
-
71
-
Number of sells
-
35
-
Price
-
$18.10
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2017
As of 31 Dec 2017 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 60,500,377 shares of stock of the company.
Largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, Rubric Capital Management LP, Broadfin Capital, LLC, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This table shows 149 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.